Cholesterol-lowering drugs could prevent the formation of blood clots in the vein by as much as 25 percent.
There's a new way to have a greater chance in surviving surgery through a drug called statin. Will it be available for all?
A new cholesterol drug was effective at reducing patients' risk of heart attacks and strokes, a new study reported.
More details from four of the nine trials revealed that the drug, alirocumab manufactured by Sanofi and Regeneron might be able to cut the number of heart attack and stroke cases.
Pharmaceutical company, Pfizer is facing a surge in lawsuits filed by women who are claiming that the cholesterol-lowering drug gave them type 2 diabetes.
A new study reported that men who take statins tend to be less active than men who did not take statins.
Use of two commonly used drugs may also prove to be the foundation of treatment for toxoplasmosis, a new study has found. Toxoplasmosis is is a parasitic infection caused by the protozoan Toxoplasma gondii.
Exercise may be the best medicine to beat disease, according to a new study.
High strength statins, or cholesterol-lowering drugs do not increase the risk of kidney injury among heart attack survivors, according to a new study.
Most people who stop taking cholesterol-lowering statins, due to mild side effects, are able to restart the same drug or a similar one without incurring any serious issues, a new study said Monday.
Statins are some of the most widely prescribed drugs in the western world.